Working… Menu

Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00570128
Recruitment Status : Completed
First Posted : December 10, 2007
Last Update Posted : August 6, 2009
Information provided by:
Eisai Inc.

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Actual Primary Completion Date : September 2008
Actual Study Completion Date : December 2008
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 March 29, 2013
May 17, 2013
2 October 7, 2014
October 9, 2014
3 March 23, 2021